Wednesday, August 20, 2008 - 3:25AM EST

Clinical Trials

1. Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20).

Author
Devauchelle-Pensec V; Pennec Y; Morvan J; Pers JO; Daridon C; Jousse-Joulin S; Roudaut A; Jamin C; Renaudineau Y; Roue IQ; Cochener B; Youinou P; Saraux A;
Institution
Hopital de la Cavale Blanche, CHU Brest, France.
Journal
Arthritis Rheum. 2007 Mar 15;57(2):310-7.
Abstract URL
Click here to view abstract

2. Efficacy prediction of cevimeline in patients with Sjogren's syndrome.

Author
Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I; Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I; Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I;
Institution
Department of Pathology, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, 230-8501, Japan.
Journal
Clin Rheumatol. 2007 Aug;26(8):1320-7. Epub 2007 Jan 13.
Abstract URL
Click here to view abstract

3. Safety and efficacy of leflunomide in primary Sjogren's syndrome: a phase II pilot study.

Author
van Woerkom JM; Kruize AA; Geenen R; van Roon EN; Goldschmeding R; Verstappen SM; van Roon JA; Bijlsma JW; van Woerkom JM; Kruize AA; Geenen R; van Roon EN; Goldschmeding R; Verstappen SM; van Roon JA; Bijlsma JW; van Woerkom JM; Kruize AA; Geenen R; van Roon EN; Goldschmeding R; Verstappen SM; van Roon JA; Bijlsma JW;
Institution
Department of Rheumatology & Clinical Immunology, F 02.127, University Medical Center, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Journal
Ann Rheum Dis. 2007 Aug;66(8):1026-32. Epub 2007 Jan 12.
Abstract URL
Click here to view abstract

4. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjogren syndrome: a uniocular evaluation.

Author
Mansour K; Leonhardt CJ; Kalk WW; Bootsma H; Bruin KJ; Blanksma LJ;
Institution
Department of Ophthalmology, Academic Hospital, University of Groningen, Groningen, The Netherlands. k.mansour@ohk.umcg.nl
Journal
Cornea. 2007 Feb;26(2):147-50.
Abstract URL
Click here to view abstract

5. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial.

Author
Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH;
Institution
Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Journal
Ann Rheum Dis. 2008 Jan;67(1):91-7. Epub 2007 Jun 1.
Abstract URL
Click here to view abstract

6. Efficacy and safety of mizoribine for the treatment of Sjogren's syndrome: a multicenter open-label clinical trial.

Author
Nakayamada S; Saito K; Umehara H; Ogawa N; Sumida T; Ito S; Minota S; Nara H; Kondo H; Okada J; Mimori T; Yoshifuji H; Sano H; Hashimoto N; Sugai S; Tanaka Y;
Institution
First Department of Internal Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan.
Journal
Mod Rheumatol. 2007;17(6):464-9. Epub 2007 Dec 20.
Abstract URL
Click here to view abstract

7. Sjogren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients.

Author
Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G; Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G; Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G; Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G; Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G;
Institution
Villamarina Hospital, Piombino, Italy. c.vitali@yahoo.it
Journal
Arthritis Rheum. 2007 Jul;56(7):2223-31.
Abstract URL
Click here to view abstract

8. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjogren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.

Author
Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS;
Institution
Oral Rehabilitation, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China.
Journal
Clin Rheumatol. 2008 Apr;27(4):429-36. Epub 2007 Sep 26.
Abstract URL
Click here to view abstract

9. Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept.

Author
Mavragani CP; Niewold TB; Moutsopoulos NM; Pillemer SR; Wahl SM; Crow MK;
Institution
Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA.
Journal
Arthritis Rheum. 2007 Dec;56(12):3995-4004.
Abstract URL
Click here to view abstract

10. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.

Author
Sall KN; Cohen SM; Christensen MT; Stein JM; Sall KN; Cohen SM; Christensen MT; Stein JM;
Institution
Sall Eye Care, Bellflower, CA, USA.
Journal
Eye Contact Lens. 2006 Jan;32(1):21-6.
Abstract URL
Click here to view abstract
Pages: 1 2 3